Australia Day Honours: Lorraine Berends of Qantas Super

Congratulations to our Board of Director, Lorraine Berends, who was awarded AM in the Australia Day honours.
Ms Lorraine Berends. Director Qantas Super Fund, Pinnacle Investment Management Received an AM in the 2024 Australia Day Honours.

Glenda Korporaal

Australia Day Honours: Lorraine Berends of Qantas Super

January 25, 2024
Congratulations to our Board of Director, Lorraine Berends, who was awarded AM in the Australia Day honours.
Read Transcript

While women have battled to rise to the top of many sectors in the finance industry, Lorraine Berends believes there is no glass ceiling in the $3 trillion superannuation sector.

Ms Berends, a director of Qantas Super and a former national chair of the Association of Superannuation Funds of Australia (ASFA), who has just been awarded AM in the Australia Day honours, says the rapid growth of the superannuation sector has provided plenty of opportunities for women to move into senior ranks.

She said the growth of the superannuation sector, which she joined straight from university, where she studied to be an actuary, in the late seventies, came at a time when there was an increasing number of Australian women coming into the workforce looking for professional careers.

“In many industries people talk about a glass ceiling, but I don’t think that there has ever been a glass ceiling in superannuation,” she said in an interview with The Australian.

“Others may disagree, but I think the opportunities in superannuation have been equally there for women and for men.”

“The investment industry and other sectors of the finance industry are still very male dominated, but even on the investment side there are a number of senior women managing large super funds which is fabulous to see.”

“There are still many glass ceilings in the law and investment banking is predominantly male, but in super there have never been the same sort of barriers.”

She said the easier growth path for women in superannuation may have also been one of timing.

“Not only was superannuation a growth industry, but it came at a time when more women were in the workforce.

“Not all were university educated but many were.”

Ms Berends never planned to go into superannuation but when she joined National Mutual as an actuary, she was put in the superannuation sector, where she worked from 1979 to 1996.

It was the start of a long career in the industry which included a move towards more specialisation on the investment management side of the business.

Her interest in super saw her become involved in the Association of Superannuation Funds of Australia, joining the board in 1997 where she served for 13 years, becoming national chair for three years from 2002 to 2005.

She was also chair of the Certified Investment Management Analysts Society for five years from 2007 to 2012.

Ms Berends has been a board member of the $8.5bn Qantas Super since 2019 and is also an independent director of Pinnacle Investment Management Group, Spheria Emerging Companies Limited and Plato Income Maximiser Limited.

Her pro bono roles include being a director of Hearts and Minds Investments Limited and an independent member of the Australian Commonwealth Games Foundation Investment Committee.

She was awarded her honour “for significant service to the financial and business sectors and to the community.”

“When I joined National Mutual, they could have put me into life insurance, but they put me in superannuation,” she said reflecting on her career in superannuation.

“Who knew that it was going to be such an enormous growth industry.”

“It was a lucky break.”

Ms Berends said the superannuation industry had gone from a product which was largely provided by employers for their staff to becoming a major industry allowing many Australians to retire with savings they would never have had, had it not been for the compulsory savings system.

“In the early days, superannuation was either corporate super or the public sector and most of the corporate funds were defined benefit.”

“Then award super came along in the 1980s and there was the superannuation guarantee and suddenly superannuation became universal.”

“Super has gone from something which employers used to provide to a big business which is changing the lives of Australians as they save for their retirement,” she said.

“It is also becoming more sophisticated in investing in a broader range of things from the initial days, when a lot of investments were in shares, fixed interest and government bonds.”

Ms Berends said there was pressure for mergers in the superannuation sector given the need for funds to hold down fees while coping with increasing cost of regulation and demands for higher level of services to members as more moved into retirement.

The number of corporate superannuation funds has now declined considerably as companies seek to exit the business given demands on the sector have increased.

Qantas Super has announced plans to seek a merger partner.

Ms Berends said smaller super funds, in particular, were finding it harder to keep their costs down given the high fixed cost of administration and investment management.

“There are enormous governance costs where the dollar amount can be the same regardless of whether you are a $8.5bn fund or a $200bn fund,” she said.

Ms Berends’ not for profit roles included becoming involved with the development of the Women in Super’s Mother’s Day Classic Fun Run which has raised a significant amount of money for breast cancer research.

She was a committee member of the fun run for 25 years.

She was asked to become a director of the Hearts and Minds Investments Fund by Chris Cuffe when it was founded in 2018.

The fund manages money invested in stocks which have been tipped by fund managers at the annual Sohn Hearts & Minds Conference, which has been going in Australia since 2016 to raise money for medical research.

The fund was set up two years later with the investment fees which would have otherwise been paid, also going to the medical research groups such as the Victor Chang Research Institute.

The annual conference and the fund have since given more than $65m to a range of medical research groups.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 25 January 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

While women have battled to rise to the top of many sectors in the finance industry, Lorraine Berends believes there is no glass ceiling in the $3 trillion superannuation sector.

Ms Berends, a director of Qantas Super and a former national chair of the Association of Superannuation Funds of Australia (ASFA), who has just been awarded AM in the Australia Day honours, says the rapid growth of the superannuation sector has provided plenty of opportunities for women to move into senior ranks.

She said the growth of the superannuation sector, which she joined straight from university, where she studied to be an actuary, in the late seventies, came at a time when there was an increasing number of Australian women coming into the workforce looking for professional careers.

“In many industries people talk about a glass ceiling, but I don’t think that there has ever been a glass ceiling in superannuation,” she said in an interview with The Australian.

“Others may disagree, but I think the opportunities in superannuation have been equally there for women and for men.”

“The investment industry and other sectors of the finance industry are still very male dominated, but even on the investment side there are a number of senior women managing large super funds which is fabulous to see.”

“There are still many glass ceilings in the law and investment banking is predominantly male, but in super there have never been the same sort of barriers.”

She said the easier growth path for women in superannuation may have also been one of timing.

“Not only was superannuation a growth industry, but it came at a time when more women were in the workforce.

“Not all were university educated but many were.”

Ms Berends never planned to go into superannuation but when she joined National Mutual as an actuary, she was put in the superannuation sector, where she worked from 1979 to 1996.

It was the start of a long career in the industry which included a move towards more specialisation on the investment management side of the business.

Her interest in super saw her become involved in the Association of Superannuation Funds of Australia, joining the board in 1997 where she served for 13 years, becoming national chair for three years from 2002 to 2005.

She was also chair of the Certified Investment Management Analysts Society for five years from 2007 to 2012.

Ms Berends has been a board member of the $8.5bn Qantas Super since 2019 and is also an independent director of Pinnacle Investment Management Group, Spheria Emerging Companies Limited and Plato Income Maximiser Limited.

Her pro bono roles include being a director of Hearts and Minds Investments Limited and an independent member of the Australian Commonwealth Games Foundation Investment Committee.

She was awarded her honour “for significant service to the financial and business sectors and to the community.”

“When I joined National Mutual, they could have put me into life insurance, but they put me in superannuation,” she said reflecting on her career in superannuation.

“Who knew that it was going to be such an enormous growth industry.”

“It was a lucky break.”

Ms Berends said the superannuation industry had gone from a product which was largely provided by employers for their staff to becoming a major industry allowing many Australians to retire with savings they would never have had, had it not been for the compulsory savings system.

“In the early days, superannuation was either corporate super or the public sector and most of the corporate funds were defined benefit.”

“Then award super came along in the 1980s and there was the superannuation guarantee and suddenly superannuation became universal.”

“Super has gone from something which employers used to provide to a big business which is changing the lives of Australians as they save for their retirement,” she said.

“It is also becoming more sophisticated in investing in a broader range of things from the initial days, when a lot of investments were in shares, fixed interest and government bonds.”

Ms Berends said there was pressure for mergers in the superannuation sector given the need for funds to hold down fees while coping with increasing cost of regulation and demands for higher level of services to members as more moved into retirement.

The number of corporate superannuation funds has now declined considerably as companies seek to exit the business given demands on the sector have increased.

Qantas Super has announced plans to seek a merger partner.

Ms Berends said smaller super funds, in particular, were finding it harder to keep their costs down given the high fixed cost of administration and investment management.

“There are enormous governance costs where the dollar amount can be the same regardless of whether you are a $8.5bn fund or a $200bn fund,” she said.

Ms Berends’ not for profit roles included becoming involved with the development of the Women in Super’s Mother’s Day Classic Fun Run which has raised a significant amount of money for breast cancer research.

She was a committee member of the fun run for 25 years.

She was asked to become a director of the Hearts and Minds Investments Fund by Chris Cuffe when it was founded in 2018.

The fund manages money invested in stocks which have been tipped by fund managers at the annual Sohn Hearts & Minds Conference, which has been going in Australia since 2016 to raise money for medical research.

The fund was set up two years later with the investment fees which would have otherwise been paid, also going to the medical research groups such as the Victor Chang Research Institute.

The annual conference and the fund have since given more than $65m to a range of medical research groups.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on 25 January 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by The Australian, published on Jan 25, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Guy Fowler & Chris Cuffe. Picture: Adam YipGuy Fowler & Chris Cuffe. Picture: Adam YipGuy Fowler & Chris Cuffe. Picture: Adam YipGuy Fowler & Chris Cuffe. Picture: Adam Yip
January 25, 2024

Fowler toasts Sohn legacy

Grounds, Fowler, and Weiss set up the Australian version, the Sohn Hearts & Minds conference in 2016, with the first meeting at the Sydney Opera House.

Read More
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
December 5, 2023

Guzman y Gomez | Performance Update

Guzman y Gomez (GYG) held its Annual General Meeting on 30 November and provided an update on its FY24 year-to-date results.

Read More
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts
October 3, 2023

Understanding the 4 pillar framework underpinning a high conviction strategy

Listen to episode one with Chief Investment Officer Charlie Lanchester and TDM Growth Partners Investment Team Members Ed Cowan and Fraser Christie. They share their unique investment philosophies and delve into two high conviction stocks recommended for the HM1 portfolio.

Read More
investing
September 5, 2023

Recap on our Australian portfolio holdings

Off the back of reporting season, we have collated some feedback from our Fund Managers on some of the Australian listed companies in the HM1 portfolio.

Read More
April 10, 2023

Introducing our new Chief Investment Officer, Charlie Lanchester

We would like to introduce our new Chief Investment Officer, Charlie Lanchester. Charlie has significant funds management experience and thrilled to be joining the HM1 team.

Read More
November 11, 2022

Sohn Hearts & Minds with Nick Griffin and Maggie O'Neill

Maggie O'Neill, HM1's Head of Marketing and Operations joined Nick Griffin, CIO of Munro Partners to discuss Hearts & Minds' history, Munro Partners' involvement and Nick's upcoming stock pitch.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.